Clinicopathological impact of Anti Smooth Muscle Antibodies in patients with Nonalcoholic Fatty Liver Disease.

CONCLUSION: ASMAbs are frequently present in NAFLD and have an impact on the histopathology of this liver disease. PMID: 30700210 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30700210?dopt=Abstract

Source: British Journal of Biomedical Science - February 1, 2019 Category: Laboratory Medicine Tags: Br J Biomed Sci Source Type: research